ATC code J07Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup J07 is part of the anatomical group J Antiinfectives for systemic use.[4]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
^"ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
^World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
^"Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
^"ATC/DDD Index 2022: code J07". WHO Collaborating Centre for Drug Statistics Methodology.
ATCcodeJ07 Vaccines is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed...
ATCcode J05 Antivirals for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
ATCcode J01 Antibacterials for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
ATCcode J04 Antimycobacterials is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes...
ATCcode J06 Immune sera and immunoglobulins is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
J7, J07, J 7 or J-7 may refer to: ATCcodeJ07 Vaccines, a subgroup of the Anatomical Therapeutic Chemical Classification System Chengdu J-7, a 1966 People's...
ATCcode J Antiinfectives for systemic use is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed...
and immunoglobulins for human use are in the ATC group J06. Vaccines for human use are in the ATC group J07. "The ATCvet classification system" (PDF). European...
ATCcode J02 Antimycotics for systemic use is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric...
Antiinfectives for systemic use. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version...
use in the United States in July 2021. The vaccine was developed under the code name "V114". It is identical to PCV13, except that it adds serotypes 22F...
Antiinfectives for systemic use. National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version...
Ixchiq AHFS/Drugs.com Ixchiq License data US DailyMed: Ixchiq Routes of administration Intramuscular ATCcode None Legal status Legal status US: ℞-only...
Uromune, also known by its developmental code name MV-140, is a polyvalent bacterial vaccine which is used in the prevention of recurrent urinary tract...
License data US DailyMed: Dengvaxia Routes of administration Subcutaneous ATCcode J07BX04 (WHO) Legal status Legal status AU: S4 (Prescription only) BR:...
poorly at body temperature (which minimizes risk to humans). Genes that code for surface proteins (targeted antigens) are combined with this host using...
com UK Drug Information Routes of administration Intramuscular injection ATCcode None Legal status Legal status AU: S4 (Prescription only) US: ℞-only with...
License data US DailyMed: Rotavirus Routes of administration By mouth ATCcode J07BH01 (WHO) J07BH02 (WHO) Legal status Legal status US: ℞-only EU: Rx-only...
Attenuated Clinical data Trade names Meruvax, other MedlinePlus a601176 ATCcode J07BJ01 (WHO) Identifiers CAS Number 1704526-12-4 Y ChemSpider none NY (what...
Global Information